Nine parameter all inclusive Drugs of Abuse Test (Dip Screen type).
Price/OrderA Rapid One-step Diagnostic Drug of Abuse Test to Screen for Nine (9) targeted Illicit and Prescription Drugs and their Metabolites at the Minimum Cutoff Sensitivity Levels Established by the National Institute on Drug Abuse, World Health Organization (WHO) and SAMHSA. Approximately 90% of abused drugs are detectable using this one simple testing device. FDA Approved. CLIA Waived.
THC (MARIJUANA) • COCAINE • PCP • OPIATES • METHAMPHETAMINE (inc. ECSTASY*) • METHADONE • AMPHETAMINES • BARBITURATES • BENZODIAZEPINES
For a comprehensive discussion on drug of abuse testing including typical detection time periods see the DRUG TESTING FAQ
The RapidCHECK Multi-Drug 9 Panel Test is an forensic, all inclusive, point of use screening test for the rapid detection of 11-nor- delta 9 -Tetrahydrocannabinol -9- carboxylic acid (THC/Marijuana), Cocaine and its metabolite, benzoylecgonine, PCP (Phencyclidine), Morphine and its related metabolites derived from opium (opiates), Methamphetamines (including Ecstasy), Methadone, Amphetamines, Barbiturates, and Benzodiazepines in human urine at or above the system concentrations levels established as standard minimums by the National Institute on Drug Abuse (NIDA), the World Health Organization (WHO) and SAMHSA as shown in the chart to the right. Note system cut-off concentrations are expressed in nanograms per milliliter. For specific information concerning the individual drug or drug classifications covered in this test screen see the DRUG FAQ.
*While Methamphetamine tests will generally detect MDMA (Ecstasy), an MDMA specific test is recommended when screening specifically for MDMA or Ecstasy use.
UUrine based screening tests for drugs of abuse range from simple immunoassay tests to complex analytical procedures. The speed and sensitivity of lateral flow based immunoassays identical to that employed in the Rapid-CHECK Multi-Drug 9 Panel Screen Test have made them the most widely accepted method for screening urine for drugs of abuse. The RapidCHECK 9 Multi-Drug Screening test is based on the principle of the highly specific immunochemical reactions of antigens and antibodies which are used for the analysis of specific compounds in human urine. The RapidCHECK 9 Multi-Drug Screen is a rapid, visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of the nine (9) targeted drugs and their metabolites listed above. For a description of these drugs of abuse along with other useful background information please refer to the DRUG FAQ page. The RapidCHECK Multi-Drug Screen Panel Test is intended as an initial forensic screen for the presence of drug or drug metabolites at the time the test is performed. Because the test requires visual interpretation, it is recommended that a person other than the test subject interpret test results.
NEGATIVE: Colored lines adjacent to each target drug name and in the control (C) regions will appear. The color intensity of the line for the target drug may be weaker or stronger than that of the control line however any line, no matter how faint should be interpreted as a negative result. Do not attempt to correlate the intensity or color of the test lines between the targeted drug panels. Also because development times vary for each target drug, results should not fully interpreted until 6-8 minutes have elapsed. Some drug panels, however, will develop test lines within 3 minutes or less producing negative results. A very faint line on the test region may indicate that the target drug in the sample is near the cutoff level for the test. While these results should be considered negative, confirmation of the sample by more analytical testing methods may be desired.
POSITIVE: Colored lines appear in the control regions (C) but do not develop in the test region. The absence of any line in any target drug test region indicates a positive result for that drug or drug metabolite. The example shown is a positive test for THC and Opiates and negative test for all other drugs. Note that test lines are not of equal intensity or color. Because of the various sensitivity cutoff level for each specific drug this result is normal.
INVALID: No line appears in the control region. Under no circumstances should a positive sample be identified until the control line (C) forms in the control test area. If the control line (C) does not form, the test result is inconclusive and the assay should be repeated with a new test device.
Note: The RapidCHECK Multi-Drug 9 panel test is used to obtain visual qualitative result and is not intended as a quantitative assay.. This assay provides only a preliminary analytical test result as to the presence of the target drug and drug metabolites at the established minimum standards above. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography! mass spectrometry (GC/MS) has been established as the preferred confirmatory method by the Substance Abuse Mental Health Services Administration (SAMHSA). Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
The RapidCHECK Multi-Drug 9 Panel Test Card screens for approximately 90% of the abused illicit or prescription drugs used today in one simple to use all inclusive device. Test cassettes are individually and hermetically sealed in a foil package clearly stamped with lot number and expiration date. A comprehensive instruction sheet is included covering greater detail on test procedure, clinical accuracy and cross-reactivity charts. The RapidCHECK Multi-Drug 9 Panel test is available in packs of 1, 3, 6, 12, 24 and 100 tests. For bulk quantities of 250 or more please contact Customer Service.
